相关实验视频

Updated: Jun 10, 2025

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

作为大脑血管疾病的标志物和调解剂的SDMA

Alexandra Riddell¹, Arun Flynn¹, Hugo Bergugnat¹

¹British Heart Foundation Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Sciences, University of Glasgow, Glasgow, United Kingdom.

Clinical science (London, England : 1979)

|October 11, 2024

概括

对称二甲基氨基 (SDMA) 与内皮功能障碍和脑血管疾病有关,包括中风. 升高的SDMA可能表明血管风险增加,并影响疾病的结果.

科学领域:

心血管科学心血管科学
腎臟病學 (nephrology) 是一種醫學專業.
神经学神经学

背景情况:

对称二甲基氨酸 (SDMA) 是一种以前被认为是生物惰性的代谢副产品.
新出现的证据将循环中的SDMA水平与内皮功能障碍和血管风险联系在一起.
本综述重点关注SDMA在脑血管疾病中的作用,特别是缺血性中风.

研究的目的:

审查关于SDMA对氧化信号传递,炎症,氧化应激和HDL功能影响的临床前证据.
分析与大脑血管风险因素和结果相关联的SDMA临床研究.
探索SDMA作为脑血管疾病的标记物和调解物的潜力.

主要方法:

关于SDMA生物效应的临床前研究的文献综述.
对研究SDMA与脑血管风险因素 (CKD,高血压,AF,动脉样硬化) 相关的临床研究的评估.
对SDMA和中风结果 (缺血和出血) 的临床数据的检查.

主要成果:

临床前数据表明,SDMA会影响内皮功能,炎症,氧化应激和高血压.
临床研究表明SDMA与常见的脑血管风险因素之间存在关联.
较高的SDMA水平与缺血性和出血性中风后的较差结果有关.

结论:

SDMA可能不仅仅是一个标志物;它可能直接影响脑血管病理.
需要进一步的机制性临床前和纵向临床研究来充分阐明SDMA的作用.
由于SDMA在脑血管疾病中是一个潜在的治疗点,因此需要进行研究.

关键词:

对称的二甲基亚尔吉尼因.大脑缺血症的大脑缺血症脑血管疾病脑血管疾病内皮质功能障碍在内皮质功能障碍甲基氨酸 (Methylarginine) 是一种含甲基氨酸的药物.

更多相关视频

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

Analysis of Cerebral Vasospasm in a Murine Model of Subarachnoid Hemorrhage with High Frequency Transcranial Duplex Ultrasound

Analysis of Cerebral Vasospasm in a Murine Model of Subarachnoid Hemorrhage with High Frequency Transcranial Duplex Ultrasound

Published on: June 3, 2021

相关概念视频

Atherosclerosis II: Clinical manifestations and prevention

Atherosclerosis II: Clinical manifestations and prevention

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...